Fonar [FONR] vs Burning Rock Biotech [BNR] Detailed Stock Comparison

Fonar Corporation

NASDAQ
Loading...

Burning Rock Biotech Ltd.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Fonar Corporation wins in 11 metrics, Burning Rock Biotech Ltd. wins in 7 metrics, with 0 ties. Fonar Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Fonar Corporation Burning Rock Biotech Ltd. Better
P/E Ratio (TTM) 16.35 -0.61 Fonar Corporation
Price-to-Book Ratio 0.70 2.76 Fonar Corporation
Debt-to-Equity Ratio 24.44 8.06 Burning Rock Biotech Ltd.
PEG Ratio 2.37 0.01 Burning Rock Biotech Ltd.
EV/EBITDA 6.37 -499.77 Fonar Corporation
Profit Margin (TTM) 7.13% -10.26% Fonar Corporation
Operating Margin (TTM) 11.74% -9.53% Fonar Corporation
EBITDA Margin (TTM) 11.74% N/A N/A
Return on Equity 6.01% -9.92% Fonar Corporation
Return on Assets (TTM) 3.16% -4.02% Fonar Corporation
Free Cash Flow (TTM) $7.45M $-98.24M Fonar Corporation
1-Year Return 31.72% 200.65% Burning Rock Biotech Ltd.
Price-to-Sales Ratio (TTM) 1.12 0.41 Burning Rock Biotech Ltd.
Enterprise Value $95.88M $253.48M Burning Rock Biotech Ltd.
EV/Revenue Ratio 0.90 3.20 Fonar Corporation
Gross Profit Margin (TTM) 37.95% N/A N/A
Revenue per Share (TTM) $16 $50 Burning Rock Biotech Ltd.
Earnings per Share (Diluted) $1.15 $-0.75 Fonar Corporation
Beta (Stock Volatility) 0.99 1.60 Fonar Corporation
Short % of Float 1.18% 0.87% Burning Rock Biotech Ltd.

Fonar Corporation vs Burning Rock Biotech Ltd. Stock Performance Analysis

Loading Price Chart...

FONR
BNR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fonar Corporation-0.10%0.95%0.90%2.86%32.66%3.08%
Burning Rock Biotech Ltd.-9.85%-28.59%-49.45%-63.08%-61.80%-55.84%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fonar Corporation31.72%13.49%5.18%16.25%827.18%55.92%
Burning Rock Biotech Ltd.200.65%285.12%-65.34%-62.16%-62.16%-62.16%

Performance & Financial Health Analysis: Fonar Corporation vs Burning Rock Biotech Ltd.

MetricFONRBNR
Market Information
Market Cap i$118.64M$221.68M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i51,89624,722
90 Day Avg. Volume i47,29531,674
Last Close$19.09$8.69
52 Week Range$13.62 - $19.16$2.80 - $41.72
% from 52W High-0.37%-79.17%
All-Time High$310.00 (Dec 06, 1982)$41.69 (Jan 22, 2026)
% from All-Time High-93.84%-79.16%
Growth Metrics
Quarterly Revenue Growth0.02%0.00%
Quarterly Earnings Growth0.05%N/A
Financial Health
Profit Margin (TTM) i0.07%-0.10%
Operating Margin (TTM) i0.12%-0.10%
Return on Equity (TTM) i0.06%-0.10%
Debt to Equity (MRQ) i24.448.06
Cash & Liquidity
Book Value per Share (MRQ)$27.01$7.49
Cash per Share (MRQ)$8.10$4.57
Operating Cash Flow (TTM) i$9.23M$-4,171,734
Levered Free Cash Flow (TTM) i$2.44M$-6,115,827
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Fonar Corporation vs Burning Rock Biotech Ltd.

MetricFONR (Apr 24, 2026)BNR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i16.35-0.61
Forward P/E iN/A-35.60
PEG Ratio i2.370.01
Price to Sales (TTM) i1.120.41
Price to Book (MRQ) i0.702.76
Market Capitalization
Market Capitalization i$118.64M$221.68M
Enterprise Value i$95.88M$253.48M
Enterprise Value Metrics
Enterprise to Revenue i0.903.20
Enterprise to EBITDA i6.37-499.77
Risk & Other Metrics
Beta i0.991.60
Book Value per Share (MRQ) i$27.01$7.49

Financial Statements Comparison: Fonar Corporation vs Burning Rock Biotech Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricFONR (2025)BNR (2024)
Revenue/Sales i104.35M515.82M
Cost of Goods Sold i61.44M153.42M
COGS % of Revenue i58.9%29.7%
Gross Profit i42.91M362.40M
Gross Margin i41.1%70.3%
Research & Development i1.58M232.29M
Operating Income (EBIT) i11.60M-322.43M
Operating Margin i11.1%-62.5%
EBITDA i16.33M-235.01M
EBITDA Margin i15.7%-45.6%
Pre-Tax Income i13.78M-340.74M
Pre-Tax Income % of Revenue i13.2%-66.1%
Income Tax i3.11M5.89M
Income Tax % of Revenue i3.0%1.1%
Net Income (Profit) i10.67M-346.63M
Profit Margin i10.2%-67.2%

Balance Sheet & Liquidity Metrics

MetricFONR (2025)BNR (2024)
Cash & Equivalents i56.33M519.85M
Total Current Assets i144.67M776.62M
Total Current Assets % of Revenue i138.6%150.6%
Total Current Liabilities i17.12M266.30M
Total Current Liabilities % of Revenue i16.4%51.6%
Long-Term Debt i35.29M27.75M
Long-Term Debt % of Revenue i33.8%5.4%
Total Shareholders Equity i160.10M580.83M
Retained Earnings i-5.29M-4.20B
Retained Earnings % of Revenue i-5.1%-814.3%
Property, Plant & Equipment i77.28M105.39M

Cash Flow Statement Comparison

MetricFONR (2025)BNR (2024)
Operating Cash Flow i9.20M-159.58M
Operating Cash Flow % of Revenue i8.8%-30.9%
Capital Expenditures i-3.79M-3.85M
Free Cash Flow i7.45M-98.24M
FCF Margin i7.1%-19.0%
Debt Repayment i-113,9400
Common Stock Repurchase i-1.81M-72,000

Short Interest & Institutional Ownership Analysis

MetricFONRBNR
Shares Short i70,96163,946
Short Ratio i1.331.93
Short % of Float i1.18%0.87%
Shares Outstanding i6.30M9.03M
Float Shares i5.13M44.05M
% Held by Insiders i12.28%3.92%
% Held by Institutions i45.39%44.73%
% Held by Public i42.33%51.35%

Dividend Analysis & Yield Comparison: Fonar Corporation vs Burning Rock Biotech Ltd.

MetricFONRBNR
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A